Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach
A year after the initial outbreak, the COVID-19 pandemic caused by SARS-CoV-2 virus remains a serious threat to global health, while current treatment options are insufficient to bring major improvements. The aim of this study is to identify repurposable drug candidates with a potential to reverse t...
Main Authors: | Andrea Gelemanović, Tinka Vidović, Višnja Stepanić, Katarina Trajković |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/2/87 |
Similar Items
-
Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach
by: Tamizhini Loganathan, et al.
Published: (2020-06-01) -
Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
by: Norihiro Sakai, et al.
Published: (2023-08-01) -
Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach
by: Simran Venkatraman, et al.
Published: (2022-01-01) -
A comparative analysis of transcriptomics of newly diagnosed multiple myeloma: exploring drug repurposing
by: Angelos Giannakoulas, et al.
Published: (2024-04-01) -
Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing
by: Leonardo Bernal, et al.
Published: (2023-02-01)